Understanding Joint Commission 360 Standards: What They Mean for SPD Teams (Part 1)
For a long time, compliance in healthcare was tied to the survey cycle. Now, that model is shifting. With the introduction of Joint Commission 360, organizations are being asked to demonstrate continuous performance—not just preparedness. As patient safety comes under increasing scrutiny, The Joint Commission is moving toward an approach built on real-time data, traceability, and consistency. The stakes are high: inconsistent sterile processing practices are still linked to surgical site infections, making SPD performance a critical piece of the patient safety puzzle.
If compliance is no longer about preparing for a moment but proving performance over time, how should SPD teams approach their daily workflows differently?
Welcome to ConCensis. In the latest episode, host Daniel Litwin sits down with Dr. Ivan Salgo, Chief Medical Officer at Censis and ASP, and Sabrina M. Ford, Market Manager of Central Sterilization at CommonSpirit, to unpack the real-world impact of Joint Commission 360 standards. Together, they explore how this updated accreditation model moves beyond checklist compliance and into a culture of continuous readiness, data-driven decision-making, and frontline accountability.
What you’ll learn…
- How to transition from last-minute survey prep to a continuous, always-ready compliance mindset powered by real-time data
- How AAMI standards and Lean principles work together to reduce variability and create consistent, high-performing SPD workflows
- Why strong documentation, traceability, and reproducible processes are now essential for proving performance and ensuring patient safety
Dr. Ivan Salgo serves as the Chief Medical Officer and Vice President at Advanced Sterilization Products (ASP), with extensive leadership experience across the medical device and life sciences industries. He has led innovation, clinical strategy, and commercialization efforts at organizations like Philips and Ortho Clinical Diagnostics, including driving market-leading cardiology technologies and securing major NIH-funded research initiatives.
Sabrina M. Ford serves as the Market Manager of Central Sterilization at CommonSpirit, where she leads SPD teams through complex compliance environments, audits, and operational challenges. With extensive hands-on leadership experience, she brings practical insight into how standards translate into day-to-day workflows and team culture. She is known for her experience guiding teams through real-world survey readiness and operational demands.
Article written by MarketScale.
